|
WO2020188105A1
|
|
Modified immune effector cells with increased resistance to cell death
|
|
GB202001593D0
|
|
Modified Immune effector cells with increased resistance to cell death
|
|
GB201917588D0
|
|
modified immune effector cells with increased resistance to cell death
|
|
EP3789485A1
|
|
Cellular therapies for cancer
|
|
EP3712257A1
|
|
Modified natural killer cells with increased resistance to cell death
|
|
US2018201661A1
|
|
Modified natural killer cells and natural killer cell lines having increased cytotoxicity
|
|
AU2017371517A1
|
|
Engineered natural killer cells and uses thereof
|
|
AU2017371514A1
|
|
Improved NK-based cell therapy
|
